These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 569446)

  • 1. The pharmacological investigations of the central action of benzydamine.
    Kocur J; Czarnecka E; Kaminska A; Wejman I
    Agressologie; 1978; 19(1):29-33. PubMed ID: 569446
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of H2 receptors blockade upon some central effects of prostacyclin in rats.
    Brus R; Krzemiński T; Juraszczyk Z; Kurcok A; Felińska W
    Pol J Pharmacol Pharm; 1985; 37(6):831-9. PubMed ID: 2870486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of benzydamine on the bioelectric activity of rabbit].
    Czarnecka E; Kocur J; Rydzyński A
    Psychiatr Pol; 1977; 11(1):15-12. PubMed ID: 847050
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of postetorphine catalepsy. Effects of clotiapine, haloperidol and rompun on postetorphine changes in concentrations of dopamine and noradrenaline in central nervous system of rats.
    Kania BF
    Acta Physiol Pol; 1980; 31(1):9-16. PubMed ID: 6103632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
    Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
    Maj J; Sowińska H; Baran L; Sarnek J
    Eur J Pharmacol; 1974 Apr; 26(1):9-14. PubMed ID: 4857604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism of dopamine and norepinephrine in rat brain after acute and chronic administration of haloperidol, loxapine and clozapine].
    Bürki HR
    Arzneimittelforschung; 1974 Jul; 24(7):983-4. PubMed ID: 4136404
    [No Abstract]   [Full Text] [Related]  

  • 9. [The influence of calcium channel blockers on the effects of haloperidol and phenamine in mice and rats].
    Kozlovskiĭ VL; Prakh'e IV; Kenunen OG
    Eksp Klin Farmakol; 1996; 59(3):12-5. PubMed ID: 8974575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High dosage haloperidol reduces cataleptic response with increased noradrenaline metabolism in the rat brain areas].
    Takashima M; Toru M
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):149-58. PubMed ID: 6687201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic action of benzydamine].
    Jansen JW
    Arzneimittelforschung; 1987 May; 37(5A):626-8. PubMed ID: 3619983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central activity of 2-amino-3-phosphonopropionic acid (AP3) and its N-methyl analog.
    Winnicka MM; Wiśniewski K; Kupczyk-Subotkowska L; Subotkowski W; Mastalerz P
    Pol J Pharmacol; 1994; 46(5):395-401. PubMed ID: 7894525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of pharmacological data on benzydamine.
    Cioli V; Corradino C; Scorza Barcellona P
    Int J Tissue React; 1985; 7(3):205-13. PubMed ID: 3899969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine].
    Allikmets LKh; Zharkovskiĭ AM; Otter MIa; Khinrikus TKh
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(5):1067-70. PubMed ID: 573939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.